dalteparin has been researched along with Pemphigoid in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dyson, SW | 1 |
Lin, C | 1 |
Jaworsky, C | 1 |
Gutjahr, A | 1 |
Heck, F | 1 |
Emtenani, S | 1 |
Hammers, AK | 1 |
Hundt, JE | 1 |
Muck, P | 1 |
Siegel, DL | 1 |
Schmidt, E | 1 |
Stanley, JR | 1 |
Zillikens, D | 1 |
Hammers, CM | 1 |
Hashimoto, T | 1 |
Kanazawa, N | 1 |
Inoue, N | 1 |
3 other studies available for dalteparin and Pemphigoid
Article | Year |
---|---|
Enoxaparin sodium-induced bullous pemphigoid-like eruption: a report of 2 cases.
Topics: Adult; Anticoagulants; Drug Eruptions; Enoxaparin; Female; Fluorescent Antibody Technique; Humans; M | 2004 |
Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium.
Topics: Autoantibodies; Autoantigens; Collagen Type XVII; Complement Activation; Complement C5a; Complement | 2019 |
Anticomplement therapy in bullous pemphigoid.
Topics: Complement Inactivator Proteins; Heparin, Low-Molecular-Weight; Humans; Pemphigoid, Bullous; Tinzapa | 2019 |